LDS/Medical Tests/Familial Hypercholesterolemia and Related Diseases Multi-Gene Panel, NGS

Familial Hypercholesterolemia and Related Diseases Multi-Gene Panel, NGS

Familial hypercholesterolemia (FH) is an inherited disorder characterized by very high levels of low-density lipoprotein cholesterol (LDL-C): usually >190 mg/dL in untreated adults. This leads to atherosclerotic plaque deposition in the proximal aorta and coronary arteries at an early age. In physical examination, untreated patients with FH typically demonstrate xanthomas (patches of yellowish cholesterol buildup) around the eyelids and within the tendons of the elbows, hands, knees, and feet. The most common cardiovascular manifestation of FH is coronary artery disease (CAD), which may cause angina and myocardial infarction; stroke occurs more rarely. Men with untreated FH have a 50% risk for a coronary event by age 50 and women with untreated FH have a 30% risk for a coronary event by age 60. FH are inherited in an autosomal dominant manner and includes heterozygous familial hypercholesterolemia (FH) and homozygous familial hypercholesterolemia (HoFH).

Heterozygous FH (HeFH) refers to hypercholesterolemia resulting from a heterozygous pathogenic variant in one of several genes (APOB, LDLR, and PCSK9). Heterozygous FH is a relatively common disorder (prevalence 1:200-1:250) and is the most common inherited cardiovascular disease. Homozygous FH (HoFH) results from biallelic (including true homozygous and compound heterozygous) pathogenic variants in the same three genes. The proteins produced from these genes are essential for the normal function of low-density lipoprotein receptors and mutations in any of them can result in either reduced or dysfunctional LDL-C receptors. Hypercholesterolemia results when low-density lipoprotein receptors are unable to remove cholesterol from the blood effectively. Most individuals with HoFH experience severe CAD by their mid-20s and the rate of either death or coronary bypass surgery by the teenage years is high. Severe aortic stenosis is also common. HoFH is much rarer than FH (prevalence 1:160,000 to 1:250,000).

The diagnosis of FH or HoFH can be established by identification of pathogenic variants in one of the three genes (APOB, LDLR, and PCSK9) known to be associated with FH/HoFH. The Centers for Disease Control (CDC) Office of Public Health Genomics has categorized genetic testing for FH as a 'Tier 1' classification, which indicates that this genetic test has important clinical implications.

Panel Components:

Although it depends on the laboratory and the clinical utility this panel uses targeted next-generation sequencing to evaluate for most common variants within genes: ABCG5, ABCG8, APOB, LDLR, LDLRAP1, and PCSK9 genes associated with familial hypercholesterolemia.

  • Diagnostic confirmation of familial hypercholesterolemia or sitosterolemia in symptomatic individuals
  • For the risk assessment of asymptomatic family members of a proband diagnosed with FH
  • Differential diagnosis of the FH from acquired (non-genetic) forms of hypercholesterolemia

Positive: At least one known heterozygous pathogenic variant or biallelic variants associated with familial hypercholesterolemia should be detected in the tested genes.

Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants Negative: No pathogenic variant detected in the tested genes.

Negative for pathogenic variant, deletions, and duplications in the tested genes

Targeted Next-Generation Sequencing, Followed by Polymerase Chain Reaction (PCR), Conventional Sanger Sequencing.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unacceptable
Lipid panel (Cholesterol, HDL, triglycerides), Total cholesterol level, LDL cholesterol (LDL-C) level, CK-MB, troponin T or troponin I.
2-3 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Genet Med. 2013;15: 948-57. [PMID: 23680767]
  • Nat Rev Dis Primers. 2017;3: 17093. [PMID: 29219151]
  • Arterioscler Thromb Vasc Biol. 2016;36:1465-6. [PMID: 27466618]
  • Curr Atheroscler Rep. 2015;17: 482. [PMID: 25612857]
  • Cardiol Clin. 2015;33: 169-79. [PMID: 25939291]
  • Gene. 2015;555: 23-32. [PMID: 25225128]
  • CMAJ. 2006;174:1124-9. [PMID: 16606962]
  • Am J Epidemiol. 2004;160: 421-9. [PMID: 15321838]
  • GeneReviews® [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK174884/
  • Genetic home reference. Available at: https://ghr.nlm.nih.gov/condition/familial-hypercholesterolemia#